A Uk Based Cost-Utility Analysis Of Indacaterol Versus Formoterol For The Maintenance Treatment Of Moderate To Severe COPD Patients

被引：0
|
作者：
Malcolm, W. A. [1 ]
Keyzor, I. [1 ]
Radwan, A. [1 ]
Asukai, Y. [2 ]
Ananthapavan, J. [2 ]
机构：
[1] Novartis Pharmaceut, Frimley, England
[2] IMS Hlth, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2157
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A UK based cost-utility analysis of indacaterol - A once-daily maintenance bronchodilator for patients with COPD
    Asukai, Yumi
    Ananthapavan, Jaithri
    Malcolm, Bill
    Radwan, Amr
    Keyzor, Ian
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Cost-utility analysis of indacaterol in Germany: A once-daily maintenance bronchodilator for patients with COPD
    Price, David
    Gray, Alastair
    Gale, Rupert
    Asukai, Yumi
    Mungapen, Laura
    Lloyd, Adam
    Peters, Lars
    Neidhardt, Katja
    Gantner, Tobias
    RESPIRATORY MEDICINE, 2011, 105 (11) : 1635 - 1647
  • [3] ECONOMIC EVALUATION OF INDACATEROL VERSUS TIOTROPIUM OR FORMOTEROL FOR PATIENTS WITH MODERATE TO SEVERE COPD IN GREECE
    Geitona, M.
    Hatzikou, M.
    Bania, E.
    VALUE IN HEALTH, 2011, 14 (07) : A493 - A493
  • [4] Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma
    Simone Gerzeli
    Carla Rognoni
    Silvana Quaglini
    Maria Caterina Cavallo
    Giovanni Cremonesi
    Alberto Papi
    Clinical Drug Investigation, 2012, 32 : 253 - 265
  • [5] Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma
    Gerzeli, Simone
    Rognoni, Carla
    Quaglini, Silvana
    Cavallo, Maria Caterina
    Cremonesi, Giovanni
    Papi, Alberto
    CLINICAL DRUG INVESTIGATION, 2012, 32 (04) : 253 - 265
  • [6] A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
    Price D.
    Asukai Y.
    Ananthapavan J.
    Malcolm B.
    Radwan A.
    Keyzor I.
    Applied Health Economics and Health Policy, 2013, 11 (3) : 259 - 274
  • [7] Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium
    Hettle, Robert
    Wouters, Hanne
    Ayres, Jon
    Gani, Ray
    Kelly, Steve
    Lion, Michaela
    Decramer, Marc
    RESPIRATORY MEDICINE, 2012, 106 (12) : 1722 - 1733
  • [8] Cost-utility analysis of Amevive™ (alefacept) in the treatment of patients with moderate-to-severe psoriasis
    Iskedjian, M
    Barkovsky, L
    Desjardins, O
    Walker, JH
    Dorkalam, M
    Shear, N
    Einarson, TR
    VALUE IN HEALTH, 2005, 8 (03) : 331 - 331
  • [9] Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
    Jefferson Antonio Buendía
    Diana Guerrero Patiño
    BMC Pulmonary Medicine, 21
  • [10] Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    BMC PULMONARY MEDICINE, 2021, 21 (01)
12345